Neoadjuvant therapies in resectable hepatocellular carcinoma: Exploring strategies to improve prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant therapies in resectable hepatocellular carcinoma: Exploring strategies to improve prognosis

Published:2024-02-29 Issue:1 Volume:18 Page:21-41
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Ma Ya-nan¹²,Jiang Xuemei²,Song Peipei¹,Tang Wei¹³

Affiliation:

1. National Center for Global Health and Medicine, Tokyo, Japan.

2. Department of Gastroenterology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.

3. Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Link

https://www.jstage.jst.go.jp/article/bst/18/1/18_2023.01436/_pdf

Reference105 articles.

1. 1. Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019; 380:1450-1462.

2. 2. Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016; 2:16018.

3. 3. Organization WH. Estimated age-standardized incidence rates (World) in 2020, liver, both sexes, all ages. 2020.

4. 4. Chan AWH, Zhong J, Berhane S, et al. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol. 2018; 69:1284-1293.

5. 5. Wakayama K, Kamiyama T, Yokoo H, Orimo T, Shimada S, Einama T, Kamachi H, Taketomi A. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection. J Surg Oncol. 2017; 115:324-329.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-25

2. Potential value and advances in research on bone mineral density (BMD) measurement in the auxiliary clinical assessment of hepatocellular carcinoma;BioScience Trends;2024

3. Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter study;Journal of Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3